Search

everythinglearnresearchcommunity

for

Search:↓

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Oral Apremilast effectively treats alopecia areata in most patients.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

AGA patients have a lower quality of life than AA patients.

Tofacitinib may help treat severe hair loss, but more research is needed.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

COVID-19 doesn't make alopecia areata worse.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.